APC News Feed | Stay Updated on Pharmacy Compounding

Novo alleges potency discrepancy, impurities in compounded semaglutide

Written by Jennifer Petska | Fri., December 1, 2023

We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no? 

(This is a late-breaking story. APC and its attorneys are reviewing and may issue a statement.)